The Patent Finder

Pyrrolopyrazine-Spirocyclic Piperidine Amides as Modulators of Ion Channels

Vertex Pharmaceuticals Incorporated

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 6 of these applications claim priority to application 61/915,937, filed Dec 13, 2013. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 8,481,552Solid Forms of Gyrase Inhibitor (R)-1-Ethyl-3-[5-[2-(1-Hydroxy-1-Methyl-ETHYL)PYRIMIDIN-5-YL]-7-(TETRAHYDROFURAN-2-YL)-1H-BENZIMIDAZOL-2-YL]UREA
In force (reinstated)
 · High confidence
UsedRemaining
Spero Therapeutics, Inc.In force (reinstated)High confidence
US 8,916,565Pyrrolopyrazine-Spirocyclic Piperidine Amides as Modulators of Ion Channels
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
US 9,511,067SUBSTITUTED SPIRO[PIPERIDINE-4,1'-Pyrrolo[1,2-a]PYRAZINE]S AS MODULATORS OF ION CHANNELS
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
US 9,181,273Morpholine-Spirocyclic Piperidine Amides as Modulators of Ion Channels
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
US 9,365,588Benzoxazines as Modulators of Ion Channels
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
US 10,385,070Chroman-Spirocyclic Piperidine Amides as Modulators of Ion Channels
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
US 9,403,839Pyran-Spirocyclic Piperidine Amides as Modulators of Ion Channels
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
US 9,108,903Amides as Modulators of Sodium Channels
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
US 9,421,196Amides as Modulators of Sodium Channels
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
US 10,233,191Fused Piperidine Amides as Modulators of Ion Channels
In force
 · High confidence
Vertex Pharmaceuticals IncorporatedIn forceHigh confidence
16 more records in this group · Pro
10 of 26 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 26, including 2 expired.
Upgrade to Pro
18 of these are in force and held by Vertex Pharmaceuticals Incorporated.
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited